NasdaqGM - Nasdaq Real Time Price USD
Amicus Therapeutics, Inc. (FOLD)
6.16
+0.09
+(1.48%)
At close: June 2 at 4:00:01 PM EDT
6.02
-0.14
(-2.27%)
After hours: June 2 at 7:45:46 PM EDT
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
28.6
ESG Risk Score for Peers
Name | Total ESG Risk score | E | S | G |
---|---|---|---|---|
ZYME Zymeworks Inc. | 29 | -- | -- | -- |
MLYS Mineralys Therapeutics, Inc. | 29 | -- | -- | -- |
FOLD Amicus Therapeutics, Inc. | 29 | -- | -- | -- |
IMTX Immatics N.V. | 29 | -- | -- | -- |
1S70.BE 1S70.BE,0P0001H7BH,0 | 29 | -- | -- | -- |
Controversy Level Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
ESG data provided by Sustainalytics, Inc. Last Updated on 5/2025
FOLD
Category Average
N/A None Controversy Level
None 4 Severe
-- FOLD
0.5 Category Average
Product Involvement Areas Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Products and Activities | Significant Involvement |
---|---|
Alcoholic Beverages | No |
Adult Entertainment | No |
Gambling | No |
Tobacco Products | No |
Animal Testing | Yes |
Fur and Specialty Leather | No |
Controversial Weapons | No |
Small Arms | No |
Catholic Values | No |
GMO | No |
Military Contracting | No |
Pesticides | No |
Thermal Coal | No |
Palm Oil | No |
Related Tickers
RARE Ultragenyx Pharmaceutical Inc.
36.14
+6.20%
ACAD ACADIA Pharmaceuticals Inc.
21.47
-0.49%
KPTI Karyopharm Therapeutics Inc.
4.1200
-1.90%
CLDX Celldex Therapeutics, Inc.
19.97
+0.96%
AGIO Agios Pharmaceuticals, Inc.
32.63
+1.68%
PTCT PTC Therapeutics, Inc.
48.83
+0.64%
FULC Fulcrum Therapeutics, Inc.
6.96
+1.24%
FATE Fate Therapeutics, Inc.
1.3000
+7.44%
KRYS Krystal Biotech, Inc.
125.36
-0.48%
DYN Dyne Therapeutics, Inc.
12.70
+6.19%